The FDA has released a summary regarding safinamide (1). Section 7.6
warns about tyramine. HealthUnlimited for PD has some good threads
regarding tyramine and MOA-B inhibitors, but the discussions seem to
predate safinamide (just newly FDA-approved for USA). Since Xadago has
been prescribed for patients in other countries, have physicians been
warning about tyramine?
1. XADAGO (safinamide) tablets, for oral use - FDA
accessdata.fda.gov/drugsatf...
ARE FDA TRIALS ALWAYS ABOVE BOARD?
Cala kIQ FDA-Approved Wearable for Acting Hand Tremor
FDA Approves Focused Ultrasound Treatment for Parkinson’s Disease
Today we announced that the US FDA has cleared IND applications for 4dpharmaplc’s LiveBiotherapeutics MRx0005 and MRx0029, Phase I
Help in understanding drugs in Parkinsons
